These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 21789563)
1. [Anatomy of the liver. What does the radiologist need to know?]. Munding J; Tannapfel A Radiologe; 2011 Aug; 51(8):655-60. PubMed ID: 21789563 [TBL] [Abstract][Full Text] [Related]
2. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session]. Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient. Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959 [TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients. Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854 [TBL] [Abstract][Full Text] [Related]
5. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos. Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670 [TBL] [Abstract][Full Text] [Related]
6. Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history. Marin D; Galluzzo A; Plessier A; Brancatelli G; Valla D; Vilgrain V Eur Radiol; 2011 Oct; 21(10):2074-82. PubMed ID: 21710271 [TBL] [Abstract][Full Text] [Related]
8. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis. Choi JY; Lee HC; Yim JH; Shim JH; Lim YS; Shin YM; Yu ES; Suh DJ J Gastroenterol Hepatol; 2011 Jun; 26(6):1004-9. PubMed ID: 21251063 [TBL] [Abstract][Full Text] [Related]
9. Imaging of atypical hemangiomas of the liver with pathologic correlation. Vilgrain V; Boulos L; Vullierme MP; Denys A; Terris B; Menu Y Radiographics; 2000; 20(2):379-97. PubMed ID: 10715338 [TBL] [Abstract][Full Text] [Related]
10. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Hussain SM; Terkivatan T; Zondervan PE; Lanjouw E; de Rave S; Ijzermans JN; de Man RA Radiographics; 2004; 24(1):3-17; discussion 18-9. PubMed ID: 14730031 [TBL] [Abstract][Full Text] [Related]
11. Focal nodular hyperplasia vs. hemangioma: computed tomography and magnetic resonance imaging findings. Karahasanoglu R; Otcu H; Selcuk T; Ucar A; Kiris A Ann Hepatol; 2011; 10(2):218-20. PubMed ID: 21502685 [TBL] [Abstract][Full Text] [Related]
12. Drug-induced vascular lesions of the liver. Zafrani ES Anat Pathol; 1997; 2():135-45. PubMed ID: 9575373 [No Abstract] [Full Text] [Related]
20. Nodular regenerative hyperplasia and focal nodular hyperplasia of the liver mimicking hepatic metastasis in children with solid tumors and a review of literature. Citak EC; Karadeniz C; Oguz A; Boyunaga O; Ekinci O; Okur V Pediatr Hematol Oncol; 2007 Jun; 24(4):281-9. PubMed ID: 17613871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]